Serum IFN-γ and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis

Allergologia et Immunopathologia

Volumn 27, Issue 5, 1999, Pages 261-264

  Keskin, G ^a   Inal, A ^b   Ali Sari, R ^c   Sengul A ^b   Sahin M ^c   Turgay, M ^c   Kinikli, G ^c  

^a Hematology Clinic   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Allergic rhinitis; IL 10. IFN ; Immunotherapy

Indexed keywords

ALLERGEN; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; DESENSITIZATION; FEMALE; HUMAN; MALE; PERENNIAL RHINITIS; POACEAE; POLLEN;

ADULT; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MALE; POACEAE; POLLEN; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0039698167     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rocklin RE. Clinical and immunological aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or asthma. J Allergy Clin Immunol 1983;72: 323-8.
2. Secrist H, Chelen CJ, Wen Y, et al. Allergen immunotherapy decreases interlukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
3. Nakagawa T, Gershwin ME. Immunotherapy of allergic diseases. Int Arch Allergy Immunol 1993;1021:117-32.
4. Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.
5. Kapsenberg ML, Hilkens CMU, Boa JD, et al. Production and modulation of T cell cytokines in atopic allergy, Int Arch Allergy Immunol 1996;110:107-13.
6. Larry Borish. IL-10: evolving concepts. J Allergy Clin Immunol 1998;101:293-7.
7. Ding L, Linsley PS, Huang LY, et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up regulation of B7 expression. J Immunol 1993;151:1224-34.
8. Ysel H, De Waal Malefyt R, Roncarolo MG, et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-84.
9. Bellinghausen I, Metz G, Enk AH, et al. Insect venom immunotherapy induces IL-10 production a Th2 to Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997;27:1131-9.
10. Gaglani B, Borish L, Bartelson BLB, et al. Local nasal immunotherapy is effective in treating weed-induced allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:259-65.
11. Fiorentino DF, Bond WF, Mosmann TR. Two types of mouse T helper cell. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
12. Editorial. Immunotherapy-anergy, deviation or suppression? Clin Exp Allergy 1998;28:911-6.
13. Wierenga EA, Snock C, De Groot I, et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-5.
14. Kapsenberg ML, Wierenga EA, Bos JD et al. Functional subsets of allergen-reactive human CD4+ T cells, Immunol Today 1991;12:392-7.
15. Umetsu TD, DeKruyff RH. Th1 and Th2 CD4+ cells in human allergic disease. J Allergy Clin Immunol 1997;100:1-6.
16. O'Brien RM, Byron KA, Varigos GA, Thomas WR. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-γ and IL-4 expression by circulating T lymphocytes. Clin Exp Allergy 1997;27:46-51.
17. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-9.
18. Akoum H, Tsicopoulos A, Vorng H, et al. Venom immunotherapy modulates interleukin 4 and interferon-γ messenger RNA expression of peripheral T lymphocytes. Immunology 1996; 87:593-8.
19. Ankie S, Gabrielsson S, Paulie S, et al. Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy. Immunol Lett 1997;57:177-81.